Applications of dynamic contrast enhanced MRI in Oncology: Measurement of tumor oxygen tension

Technology in Cancer Research and Treatment

Volumn 1, Issue 1, 2002, Pages 29-38

  Wang, Z ^a   Su, M Y ^a   Nalcioglu, O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCULATION; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIFFUSION COEFFICIENT; MALE; MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; OXYGEN TENSION; PERFORMANCE; RAT; TUMOR; TUMOR VASCULARIZATION;

EID: 0005320774     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460200100104     Document Type: Article

References (67)

1. Gray, L. H., Conger, A.D., Ebert, M., Hornsey, S., Scott, O.C.A., The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26, 628-654 (1953).
2. Hill, R.P. and Pallavicini, M.G., Hypoxia and the radiation response of tumors. Adv. Exp. Med. Biol. 159, 17-35 (1983).
3. Kallman, R.F., and Dorie, M.J., Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response. Int. J. Radiat. Oncol. Biol. Phys. 12, 681-685 (1986).
4. Okunieff, P., Hoeckel, M., Dunphy, E.P., Schlenger, K., Knoop, C., and Vaupel, P., Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int. J. Radiat. Oncol. Biol. Phys. 26, 631-636 (1993).
5. Hall, E.J., Radiobiology for the radiologist, 4th edition, Philadelphia, J. B. Lippincott Company, pp. 133-151 (1994).
6. Cater, D.B. and Silver, I.A., Quantitative measurements of oxygenation in normal tissues and in the tumors of patients before and after radiotherapy. Acta Radiol 53, 233-256 (1960).
7. Hockel, M., Schlenger, K., Knoop, C., and Vaupel, P., Oxygenation of carcinomas of the uterine cervix: evaluation by computerized 02 tension measurement. Cancer Res. 51, 6098-6102 (1991).
8. Lartigau, E., Le Ridant, A-M., Lambin, P., Weeger, P., Martin, L., Sigal, R., Lusinchi, A., Luboinski, B., Eschwege, F., and Guichard, M., Oxygenation of head and neck tumors. Cancer 71, 2319-2325 (1993).
9. 2 tension measurements. Cancer Res. 51, 3316-3322 (1991).
10. Goldacre, R.J., and Sylven, B., On the access of blood-borne dyes to various tumor regions. Br. J. Cancer 16, 306-322 (1962).
11. Song, C.W., and Levitt, S.H., Quantitative study of vascularity in Walker carcinoma 256. Cancer Res. 31, 587-589 (1971).
12. 19F PBSR EPI of hexafluorobenzene. Magn. Reson. Imag. 15, 971-981 (1997).
13. 31P magnetic resonance spectroscopy. Magn. Reson. Imag. 14, 514-551 (1996).
14. 19F in a rabbit abscess model. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 22, 1449-1454 (1994).
15. 19F NMR relaxometry of a perfluorocarbon emulsion. Magn. Reson. Med. 29, 303-310 (1993).
16. R. P. Mason, P. P. Antich, E. E. Bobcock, A. Constantinescu, P. Peschke, and E. W. Hahn, Non-invasive determination of tumor oxygen tension and local variation with growth. Int. J. Radiat. Oncol. Biol. Phys. 29, 95-103 (1994).
17. 19F inversion-recovery echo-planar imaging of perfluoro15-crown-5-ether. Magn. Reson. Med. 32, 88-97 (1994).
18. 19F NMR indicator of tumor oxygenation. NMR. Biomed. 9, 125-134 (1996).
19. Jao, J-C., and Nalcioglu, O., Measurement of pO2 by spatially localized double-voxel F-19 imaging and spectroscopy of PFB. Physica Medica XI, 121-126 (1995).
20. 19F NMR imaging of the vascular system in vivo. Magn. Reson. Imag. 5, 279-285 (1987).
21. 19F MRI study in tumor-bearing mice. Magn. Reson. Imag. 7, 475-485 (1989).
22. Ozdemirel, B., and Nalcioglu, O., Correction of chemical-shift artifacts in multislice F-19 imaging with perfluorooctyl bromide. Magn. Reson. Med. 23, 324-332 (1992).
23. Lee, H.K., and Nalcioglu, O., Reblurred deconvolution method for chemical shift removal in F-19 (PFOB) MR imaging. J. Magn. Reson. Imag. 2, 53-61 (1992).
24. Lee, H.K., and Nalcioglu, O., Reduced-bandwidth method for F-19 imaging of perflubron. J. Magn. Reson. Imag. 2, 563-568 (1992).
25. 19F imaging of PFOB: a robust signed magnitude method. Magn. Reson. Med. 23, 254-263 (1992).
26. 19F NMR spectroscopy of perfluorocarbon. Magn. Reson. Med. 29, 296-302 (1993).
27. Sotak, C.H., Hees, P.S., Huang, H.N., Hung, M.H., Krespan, C.G., and Raynolds, S., A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn. Reson. Med. 29, 188-195 (1993).
28. 19F NMR. Magn. Reson. Med. 29, 446-458 (1993).
29. McGovern, K.A., Schoeniger, J.S., Wehrle, J.P., Ng, C.E., and Glickson, J.D., Gel-entrapment of perfluorocarbons: a fluorine-19 NMR spectroscopic method for monitoring oxygen concentration in cell perfusion systems. Magn. Reson. Med. 29, 196-204 (1993).
30. 19F-MRI. Magn. Reson. Med. 34, 738-745 (1995).
31. Harms, S.E., Flaming, D.P., Hesley, K.L., and Evans, W.P., Magnetic resonance imaging of the breast. Magn. Reson. Quarterly 8, 139-155 (1992).
32. Flicinger, F.W., Allison, J.D., Sherry, R.M., and Wright, J.C., Differentiation of benign from malignant breast masses by timeintensity evaluation of contrast enhanced MRI. Magn. Reson. Imag. 11, 617-620 (1993).
33. Mussurakis, S., Buckley, D.L., Bowsley, S.J., Carleton, P.J., Fox, J.N. Tumbull, L.W., and Horsman, A., Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmcokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinomna. Investive Radiology 30, 650-662 (1995).
34. Larsson, H.B., Stubgaard, M., Frederiksen, J.L., Jensen., M., Henriksen, O., and Paulson, O.B., Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn. Reson. Med. 16, 117-131 (1990).
35. Tofts, P.S. and Kermode, A., Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn. Reson. Med. 17, 357-367 (1991).
36. Brix, G., Semmler, Port, W.R., Schad, L.R., Layer, G., and Lorenz, W.J. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J. Comput. Assist. Tomogr. 15, 621-628 (1991).
37. Gowland, P., Mansfield, P., Bullock, P., Stehling, M., Worthington, B., and Firth, J., Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo planar imaging. Magn. Resort Magii. Reson. Med. 26, 241-258 (1992).
38. Kenney, J., Schmiedl, U., Maravilla, K., Starr, F., Graham, M., Spence, A., and Nelson, J., Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA. Magn. Reson. Med. 27, 68-75 (1992).
39. Su, M-Y., Jao, J-C., and Nalcioglu, O., Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn. Reson. Med. 32, 714-724 (1994).
40. Su, M-Y., Najafi, A.A., and Nalcioglu, O., Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn. Reson. Med. 34, 402-411 (1995).
41. Tofts, P.S., Berkowitz, B., and Schnall, M.D., Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn. Reson. Med. 33, 564-568 (1995).
42. Tofts, P.S., Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imag. 7, 91-101 (1997).
43. Krogh, A., The number and distribution of capillaries in muscle with the calculation of oxygen pressure necessary for supplying the tissue. J. Physiol. 52, 409-515 (1918).
44. Hyman, W.A., A simplified model of the oxygen supply function of capillary blood flow. Adv. Exp. Med. Biol. 37B, 835-838 (1973).
45. 2 distributions in Krogh cylinder and solid cylinder models. Respir. Physiol. 64, 241-251 (1986).
46. 2 profiles in working red muscle. Respir. Physiol. 79, 255-278 (1990).
47. Groebe, K., and Thews, G., Basic mechanisms of diffusive and diffusion-related oxygen transport in biological systems: a review. Adv. Exp. Med. Biol. 317, 21-33 (1992).
48. Intaglietta, M., Johnson, P.C., and Winslow, R.M., Microvascular and tissue oxygen distribution. Cardiovas. Res. 32, 632-643 (1996).
49. Fine, D.L., Arthur, L.O., and Young, L.J., Cell culture factors influencing in vitro expression of mouse mammary tumor virus. In Vitro 12, 693-701 (1976).
50. Parhami, P., and Fung, B.M., Fluorine-19 relaxation study of perfluoro chemicals as oxygen carriers. J. Phys. Chem. 87, 1928-1931 (1983).
51. Kuwatsuru, R., Shames, D.M., Muhler, A., Mintorovitch, J., Vexler, V., Mann, J.S., Cohn, F., Price, D., J. Huberty, J., and Brasch, R.C., Quantification of tissue plasma volume in the rat by contrastenhanced magnetic resonance imaging. Magn. Reson. Med. 30, 76-81 (1993).
52. Shames, D.M., Kuwatsuru, R., Vexler, V.S., Muhler, A., and Brasch, R.C., Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn. Reson. Med. 29, 616-622 (1993).
53. Schwickert, H.C., Roberts, T.P., DShames, D.M., van Dijke, C.F., Disston, A., Muhler, A., Mann, J.S., and Brasch R.C., Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn. Reson. Med. 34, 845-852 (1995).
54. Demsar, F., Roberts, T.P., Schwickert, H., Shames, D.M., van Dijke, C.F., Mann, J.S., Saeed, M., and Brasch, R.C., A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn. Reson. Med. 37, 236-42 (1997).
55. Thomlinson, R.H. and Gray, L.H., The histological structure of some human lung cancer and the possible implications for radiotherapy. Br. J. Cancer 9, 539-549 (1955).
56. Brown, J.M., Tumor hypoxia, drug resistance, and Metastases. J. Natl. Cancer. Inst. 82, 338-339 (1990).
57. Vaupel, P., Schlenger, K., and Hoeckel, M., Blood flow and tissue oxygenation of human tumors: an update. Adv. Exp. Med. Biol. 317, 139-151 (1992).
58. Karczmar, G.S., Kuperman, V.Y., River, J.N., Lewis, M.Z., and Lipton, M.J., Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Investigative Radiology 29, S161-S163 (1994).
59. 31P MRS. NMR Biomed. 9, 208-216 (1996).
60. 2 in a RIF-1 tumor. Magn. Reson. Med. 34, 515-519 (1995).
61. Less, J.R., Skalak, T.C., Sevick, E.M., and Jain, R.K., Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res. 51, 265-273 (1991).
62. Su, M-Y., Wang, Z., Roth, G.M., Lao, X., Samoszuk, M.K., and Nalcioglu, O., Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn. Reson. Med. 36, 868-877 (1996).
63. Weinmann, H.J., Laniado, M., and Mutzel, W., Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol. Chem. Phys. Med. NMR 16, 167-172 (1984).
64. 99mTc(DTPA) in rats. Magn. Reson. Imag. 8, 567-575 (1990).
65. Braunschweiger, P.G., Schiffer, L.M., and Furmanski, P., IH-NMR relaxation times and water compartmentalization in experimental tumor models. Magn. Reson. Imag. 4, 335-342 (1986).
66. Donahue, K.M., Burstein, D., Manning, W.J., and Gray, M.L., Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn. Reson. Med. 32, 66-76 (1994).
67. Shuter, B., Tofts, P.S., Wang, S.C., and Pope, J.M., The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn. Reson. Imag. 14, 243-253 (1996).